Skip to main content
. Author manuscript; available in PMC: 2020 Jan 28.
Published in final edited form as: J Invest Dermatol. 2018 Dec 10;139(6):1339–1348. doi: 10.1016/j.jid.2018.11.028

Figure 2. IgG2a(TA99) specifically accumulates in s.c. B16F10 tumors.

Figure 2

Microscopic fluorescence analysis of organs from B16F10 tumor bearing mice, 24 hours after intravenous administration of FITC labelled IgG2a(TA99) (A) or IgG2a(KSF) (B) (green, Alexa Fluor 488). Blood vessels stained with anti-CD31 (red, Alexa Fluor 594). Magnification 10x, scale bar = 100μm.